With 1.87 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.73 million shares. During the session, the Beverages – Non-Alcoholic company that operates in wider Consumer Defensive sector, reached to the highest price of $89.55 whereas the lowest price it dropped to was $88.045. The 52-week range on CCEP shows that it touched its highest point at $91.29 and its lowest point at $68.45 during that stretch. It currently has a 1-year price target of $98.36. With its current market cap of 40.62 billion, CCEP has annualized dividend of $2.09 while the current yield stands at 2.37%. CCEP paid its most recent dividend on 1731628800, while the ex-dividend date for that was 1731628800. Beta for the stock currently stands at 0.72.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CCEP was up-trending over the past week, with a rise of 0.28%, but this was up by 4.77% over a month. Three-month performance surged to 15.52% while six-month performance rose 14.26%. The stock gained 27.57% in the past year, while it has gained 14.76% so far this year. A look at the trailing 12-month EPS for CCEP yields 3.33 with Next year EPS estimates of 5.29. EPS is expected to grow by 8.64% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 4.96%.
Float and Shares Shorts:
At present, 474.92 million CCEP shares are outstanding with a float of 215.27 million shares on hand for trading. On 2025-03-31, short shares totaled 4.36 million, which was 95.0 higher than short shares on 1740700800. In addition to Mr. Damian Paul Gammell as the firm’s CEO & Executive Director, Mr. Ed Walker serves as its Chief Financial Officer.
Institutional Ownership:
Through their ownership of 0.35721 of CCEP’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CCEP since 4 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With CCEP analysts setting a high price target of 102.86962 and a low target of 63.33485, the average target price over the next 12 months is 90.51078. Based on these targets, CCEP could surge 16.7% to reach the target high and fall by -28.15% to reach the target low. Reaching the average price target will result in a growth of 2.68% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $4.26302 being high and $3.86122 being low. For CCEP, this leads to a yearly average estimate of $4.07682. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.
